Jacobio Pharmaceuticals Group Co. Ltd. announced that, under its ongoing on-market share repurchase plan, it has repurchased a total of 326,400 shares for a total consideration of approximately HK$2.67 million. The company stated it will continue to monitor market conditions and may further exercise the shareholders' mandate to repurchase shares as appropriate.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobio Pharmaceuticals Group Co. Ltd. published the original content used to generate this news brief on September 26, 2025, and is solely responsible for the information contained therein.